Growth-Stage Lab Platform Relocation
The Situation
A clinical-stage biotech company had outgrown its 28,000 SF headquarters and lab facility in San Diego with 14 months remaining on its lease. The company had just closed a Series C round and needed to consolidate R&D, manufacturing, and administrative functions under one roof — while maintaining uninterrupted GMP operations during the transition. Timing was critical: any gap in lab availability would delay an FDA submission timeline.
The Approach
We began with a full operational needs assessment, mapping every workflow dependency between the lab, cleanroom, and office functions. Site selection focused on a 12-building shortlist across the Torrey Pines and Sorrento Valley corridors, evaluated against power redundancy, HVAC zoning capacity, and landlord willingness to fund tenant improvements at the scale required. Lease negotiations were structured to include an early-access period for buildout overlap, ensuring the team could validate the new cleanroom environment before surrendering the existing space. Financial analysis modeled three scenarios against the client's cash runway to align lease economics with fundraising milestones.
The Outcome
The client secured a 62,000 SF purpose-built facility with a lease structure that deferred significant rent obligation until after projected revenue milestones. The overlapping occupancy period preserved the FDA timeline with zero operational disruption.
- 62,000 SF consolidated facility
- Zero days of operational downtime
- Lease structured around fundraising milestones